Is menopause a potential risk factor for severity of COVID-19: A retrospective cross-sectional study?

• Main Authors: Veerendra Arya, Rashmi Bajpai, Adarsh Bajpai, Navdeep Singh Kathuria
• Format: Article
• Language: English
• Published: Manipal College of Medical Sciences, Pokhara 2021-09-01
• Series: Asian Journal of Medical Sciences
• Subjects: covid-19; menopause; d-dimer; c-reactive protein; immunity
• Online Access: https://www.nepjol.info/index.php/AJMS/article/view/37811

Background: The world is struggling with the rising number of covid-19 cases. Few studies are available to propose the effect of menopause on covid-19. We are submitting a research article targeted at identifying menopause as an independent risk factor for severe Covid-19. Aims and Objectives: Determine whether menopausal women are at higher risk of developing severe Covid-19 infection as compared to menstruating women of the same age group. Materials and Methods: A retrospective cross-sectional study that included patients ages varies from 40 to 55 years from the medical record department of LNMC Bhopal, India. We enrolled 65 female patients after analysing records of 2500 patients. We divided the entire study population into two groups, the menopause group, and the non-menopausal group. Result: Out of 65 patients, 27 patients were in the menopause group, and 38 patients were in the non-menopause group. The mean D-dimer in the menopause group is 1100.78 ng/ml and in the non-menopause group is 727.63 ng/ml, which is statistically significant. (p-value 0.04) The mean value of C-Reactive protein is 27.11 mg/l and 16.74 mg/l among the menopause and non-menopause groups, respectively (p-value0.041). Twelve out of 17 patients who develop moderate-to-severe disease belong to the menopause group and five patients in the non-menopause group (p-value 0.005). Conclusion: In the present study, we witnessed that the disease is more severe in the menopause group than in the non-menopause group (p<0.005). This study can help recognize the high-risk cases and may be helpful to plan the treatment policies for the menopausal women who contract the Covid-19.